This topic contains a solution. Click here to go to the answer

Author Question: The use of which drug or drugs is/are associated with later development of pulmonary artery ... (Read 59 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
The use of which drug or drugs is/are associated with later development of pulmonary artery hypertension (PAH)?
 
  a. Amiodarone and ambrisentan
  b. Macitentan and cyclophosphamide
  c. Fenfluramine/phentermine
  d. Disease-modifying antirheumatic drugs

Question 2

What is the most common route used to deliver short-acting beta-adrenergic agonists?
 
  a. Oral
  b. Intravenous
  c. Transdermal
  d. Inhalation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joewallace

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

ANS: C

Answer to Question 2

ANS: D





 

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Walt Disney helped combat malaria by making an animated film in 1943 called The Winged Scourge. This short film starred the seven dwarfs and taught children that mosquitos transmit malaria, which is a very bad disease. It advocated the killing of mosquitos to stop the disease.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

For a complete list of videos, visit our video library